(HealthDay)—The rate of 30-day index readmissions after acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is 19.2 percent, according to a study published in the July issue of the Annals of the American Thoracic Society. David M. Jacobs, Pharm.D., Ph.D., from the University of Buffalo in New York, and colleagues analyzed the Nationwide Readmission Database […]
Home »
Azithromycin cuts pulmonary exacerbation in CF with early Pseudomonas aeruginosa
(HealthDay)—For children with cystic fibrosis (CF) and early Pseudomonas aeruginosa (Pa) infection, the risk of pulmonary exacerbation is significantly reduced with the addition of azithromycin to tobramycin inhalation solution (TIS), according to a study published online June 11 in the American Journal of Respiratory and Critical Care Medicine. Nicole Mayer-Hamblett, Ph.D., from the University of […]